Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice

ChemMedChem. 2011 Jan 3;6(1):49-53. doi: 10.1002/cmdc.201000377.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents* / administration & dosage
  • Antineoplastic Agents* / chemical synthesis
  • Antineoplastic Agents* / metabolism
  • Colonic Neoplasms / drug therapy
  • Colorectal Neoplasms / drug therapy
  • Dendrimers* / administration & dosage
  • Dendrimers* / chemical synthesis
  • Dendrimers* / metabolism
  • Disease Models, Animal
  • Drug Carriers* / administration & dosage
  • Drug Carriers* / chemical synthesis
  • Drug Carriers* / metabolism
  • Drug Evaluation, Preclinical
  • Endosomes / metabolism
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Oligopeptides* / administration & dosage
  • Oligopeptides* / chemical synthesis
  • Oligopeptides* / metabolism
  • Solubility

Substances

  • Antineoplastic Agents
  • Dendrimers
  • Drug Carriers
  • Oligopeptides
  • tubulysin D